Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oronza A Botrugno

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|December 26, 2015
Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor AgentPaola Vianello, Oronza A Botrugno, Anna Cappa, et al.
European Journal of Medicinal Chemistry|March 14, 2015
Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blastsSergio Valente, Veronica Rodriguez, Ciro Mercurio, et al.
Cell Death & Disease|May 4, 2026
The histone methyltransferase NSD3 oncogene triggers ribosomal DNA transcription, interfering with FOSL2 in cancerFederica Corigliano, Marco Gaviraghi, Alessio Lupi, et al.
Chemmedchem|February 1, 2020
Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target ModulationRossella Fioravanti, Annalisa Romanelli, Nicola Mautone, et al.
Nature Biotechnology|October 12, 2021
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatinMartina Tedesco, Francesca Giannese, Dejan Lazarević, et al.
Antioxidants & Redox Signaling|April 22, 2015
Redox-Mediated Suberoylanilide Hydroxamic Acid Sensitivity in Breast CancerFerdinando Chiaradonna, Iros Barozzi, Claudia Miccolo, et al.
Journal of Medicinal Chemistry|February 11, 2017
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 2: Structure-Based Drug Design and Structure-Activity RelationshipPaola Vianello, Luca Sartori, Federica Amigoni, et al.
Journal of Medicinal Chemistry|February 11, 2017
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 1: High-Throughput Screening and Preliminary ExplorationLuca Sartori, Ciro Mercurio, Federica Amigoni, et al.
Nature Communications|February 3, 2025
Early tolerance and late persistence as alternative drug responses in cancerSimona Punzi, Davide Cittaro, Guido Gatti, et al.
Gut|July 3, 2023
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cellsAlessia Potenza, Chiara Balestrieri, Martina Spiga, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|December 26, 2015
Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor AgentPaola Vianello, Oronza A Botrugno, Anna Cappa, et al.
European Journal of Medicinal Chemistry|March 14, 2015
Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blastsSergio Valente, Veronica Rodriguez, Ciro Mercurio, et al.
Cell Death & Disease|May 4, 2026
The histone methyltransferase NSD3 oncogene triggers ribosomal DNA transcription, interfering with FOSL2 in cancerFederica Corigliano, Marco Gaviraghi, Alessio Lupi, et al.
Chemmedchem|February 1, 2020
Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target ModulationRossella Fioravanti, Annalisa Romanelli, Nicola Mautone, et al.
Nature Biotechnology|October 12, 2021
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatinMartina Tedesco, Francesca Giannese, Dejan Lazarević, et al.
Antioxidants & Redox Signaling|April 22, 2015
Redox-Mediated Suberoylanilide Hydroxamic Acid Sensitivity in Breast CancerFerdinando Chiaradonna, Iros Barozzi, Claudia Miccolo, et al.
Journal of Medicinal Chemistry|February 11, 2017
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 2: Structure-Based Drug Design and Structure-Activity RelationshipPaola Vianello, Luca Sartori, Federica Amigoni, et al.
Journal of Medicinal Chemistry|February 11, 2017
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 1: High-Throughput Screening and Preliminary ExplorationLuca Sartori, Ciro Mercurio, Federica Amigoni, et al.
Nature Communications|February 3, 2025
Early tolerance and late persistence as alternative drug responses in cancerSimona Punzi, Davide Cittaro, Guido Gatti, et al.
Gut|July 3, 2023
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cellsAlessia Potenza, Chiara Balestrieri, Martina Spiga, et al.
Pageof 4